€105.00
Product information
| Active substances | HYALURONIC ACID, SODUM CHLORIDE |
|---|---|
| Manufacturer | Bio-Science |
| Pack size | 1 x 10ml Pre-Filled Syringe |
| Strength | 20mg/ml |
We guarantee your order will arrive quickly. Most parcels are delivered within 5–10 business days, ensuring you get the products you need when you need them.
Enjoy personalized support with a dedicated account manager. From product selection to tracking, you’ll always have a trusted partner by your side.
Shop confidently from our selection of medical products. Each item is available for fast, reliable delivery, so your practice stays fully stocked.
We supply only authentic products, backed by full traceability. Every order comes with confidence, transparency, and assurance of verified sourcing.
HYACORP MLF2® BODY CONTOURING represents an advanced hyaluronic acid-based dermal filler specifically engineered for large-scale body contouring applications. This sophisticated body sculpting filler utilizes cross-linked hyaluronic acid technology with a concentration of 20mg/ml, delivered in a convenient 10ml pre-filled syringe format. Manufactured by Bio-Science, this HYACORP product maintains pharmaceutical-grade standards.
When you buy HYACORP body contouring MLF2, you receive a formulation with a larger particle size distribution ideal for substantial volume restoration in areas such as buttocks, calves, and other major body regions. Each HYACORP MLF2® unit delivers consistent results in body sculpting procedures.
Administration of HYACORP body contouring MLF2 10ml requires a proper injection technique and adherence to sterile protocols. The recommended injection depth varies according to the treatment area, with both subcutaneous and supraperiostal application methods being appropriate.
Each 10ml syringe provides sufficient volume for comprehensive treatment. Practitioners should perform procedures under local anesthesia, typically incorporating lidocaine for patient comfort. Treatment sessions generally require 60-90 minutes.
Post-treatment protocols recommend avoiding intensive physical activity for one week. Patients may resume normal activities immediately after treatment.
HYACORP MLF2® contains precisely formulated active and inactive components. The primary ingredient consists of cross-linked hyaluronic acid at 20.0mg per ml, complemented by non-cross-linked hyaluronic acid at 2.0mg per ml. This dual hyaluronic configuration provides immediate volume and sustained support.
Sodium chloride at 6.9 mg/mL maintains isotonic conditions, ensuring tissue compatibility. The hyaluronic acid derives from bacterial fermentation rather than animal sources.
Proper storage maintains the integrity and sterility of HYACORP MLF2. Store at room temperature between 2-25°C, avoiding temperature extremes. Protect from direct sunlight and freezing conditions.
Maintain original packaging until use to preserve sterility. Do not use beyond the expiration date or if the packaging shows damage.
Several medical conditions preclude the use of HYACORP MLF2® BODY CONTOURING. Patients with known hypersensitivity to hyaluronic acid should not receive treatment. Active skin infections at the intended injection site represent absolute contraindications.
Pregnancy and breastfeeding constitute contraindications due to insufficient safety data. Patients with autoimmune disorders affecting connective tissue require careful pre-treatment evaluation.
Healthcare providers must maintain strict aseptic technique throughout the injection procedure to prevent bacterial contamination. Proper patient selection and pre-treatment assessment minimize the risks of complications and optimize treatment outcomes.
Avoid injection into blood vessels, as intravascular placement may result in serious complications, including tissue necrosis. Practitioners should possess thorough anatomical knowledge before administering HYACORP products.
Bio-Science manufactures HYACORP MLF2® BODY CONTOURING under stringent quality control standards. The product is marked with CE for European market distribution, indicating compliance with medical device regulations and safety requirements.
Manufacturing facilities operate under Good Manufacturing Practice guidelines, ensuring consistent product quality and sterility. Each batch undergoes comprehensive testing before release.
